Regulatory Compliance And Advanced Solutions For Aseptic Environmental Monitoring
Compounding pharmacies operate in a high-stakes environment, producing patient-specific sterile products within compact cleanrooms. As global regulatory expectations like EU GMP Annex 1 evolve, the shift toward a risk-based contamination control strategy (CCS) has become essential. While manual records and periodic testing once sufficed, modern standards demand a more integrated approach to ensure the stability of the aseptic process.
Developing a holistic monitoring strategy involves more than just meeting limits; it requires understanding the interplay between non-viable particles, viable microbiological growth, and environmental parameters like differential pressure. By moving toward continuous monitoring and automated data management, facilities can transition from reactive compliance to proactive process control. This evolution allows for early detection of deviations, ensuring that every batch meets the highest standards of safety and quality. Discover how to align your cleanroom qualification with routine monitoring to create a future-proof compliance framework.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.